153 related articles for article (PubMed ID: 16155203)
21. Crystal structure of the SH3 domain of betaPIX in complex with a high affinity peptide from PAK2.
Hoelz A; Janz JM; Lawrie SD; Corwin B; Lee A; Sakmar TP
J Mol Biol; 2006 Apr; 358(2):509-22. PubMed ID: 16527308
[TBL] [Abstract][Full Text] [Related]
22. Targeting the SH3 domain of human osteoclast-stimulating factor with rationally designed peptoid inhibitors.
Han S; Liu Q; Wang F; Yuan Z
J Pept Sci; 2016 Aug; 22(8):533-9. PubMed ID: 27443979
[TBL] [Abstract][Full Text] [Related]
23. The high-resolution NMR structure of the R21A Spc-SH3:P41 complex: understanding the determinants of binding affinity by comparison with Abl-SH3.
Casares S; Ab E; Eshuis H; Lopez-Mayorga O; van Nuland NA; Conejero-Lara F
BMC Struct Biol; 2007 Apr; 7():22. PubMed ID: 17407569
[TBL] [Abstract][Full Text] [Related]
24. The SH3 domain of a M7 interacts with its C-terminal proline-rich region.
Wang Q; Deloia MA; Kang Y; Litchke C; Zhang N; Titus MA; Walters KJ
Protein Sci; 2007 Feb; 16(2):189-96. PubMed ID: 17189480
[TBL] [Abstract][Full Text] [Related]
25. Structural basis of PxxDY motif recognition in SH3 binding.
Aitio O; Hellman M; Kesti T; Kleino I; Samuilova O; Pääkkönen K; Tossavainen H; Saksela K; Permi P
J Mol Biol; 2008 Sep; 382(1):167-78. PubMed ID: 18644376
[TBL] [Abstract][Full Text] [Related]
26. SH3 domain recognition of a proline-independent tyrosine-based RKxxYxxY motif in immune cell adaptor SKAP55.
Kang H; Freund C; Duke-Cohan JS; Musacchio A; Wagner G; Rudd CE
EMBO J; 2000 Jun; 19(12):2889-99. PubMed ID: 10856234
[TBL] [Abstract][Full Text] [Related]
27. Solution structure of the PX domain, a target of the SH3 domain.
Hiroaki H; Ago T; Ito T; Sumimoto H; Kohda D
Nat Struct Biol; 2001 Jun; 8(6):526-30. PubMed ID: 11373621
[TBL] [Abstract][Full Text] [Related]
28. 3D domain swapping in a chimeric c-Src SH3 domain takes place through two hinge loops.
Cámara-Artigas A; Martínez-Rodríguez S; Ortiz-Salmerón E; Martín-García JM
J Struct Biol; 2014 Apr; 186(1):195-203. PubMed ID: 24556574
[TBL] [Abstract][Full Text] [Related]
29. Directed Evolution of a Highly Specific FN3 Monobody to the SH3 Domain of Human Lyn Tyrosine Kinase.
Huang R; Fang P; Hao Z; Kay BK
PLoS One; 2016; 11(1):e0145872. PubMed ID: 26731115
[TBL] [Abstract][Full Text] [Related]
30. The SH3 Domain Acts as a Scaffold for the N-Terminal Intrinsically Disordered Regions of c-Src.
Maffei M; Arbesú M; Le Roux AL; Amata I; Roche S; Pons M
Structure; 2015 May; 23(5):893-902. PubMed ID: 25914053
[TBL] [Abstract][Full Text] [Related]
31. Structural basis of the recognition of the SAMP motif of adenomatous polyposis coli by the Src-homology 3 domain.
Kaieda S; Matsui C; Mimori-Kiyosue Y; Ikegami T
Biochemistry; 2010 Jun; 49(25):5143-53. PubMed ID: 20509626
[TBL] [Abstract][Full Text] [Related]
32. Identification and biophysical assessment of the molecular recognition mechanisms between the human haemopoietic cell kinase Src homology domain 3 and ALG-2-interacting protein X.
Shi X; Opi S; Lugari A; Restouin A; Coursindel T; Parrot I; Perez J; Madore E; Zimmermann P; Corbeil J; Huang M; Arold ST; Collette Y; Morelli X
Biochem J; 2010 Oct; 431(1):93-102. PubMed ID: 20670214
[TBL] [Abstract][Full Text] [Related]
33. Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.
Polverini E; Rangaraj G; Libich DS; Boggs JM; Harauz G
Biochemistry; 2008 Jan; 47(1):267-82. PubMed ID: 18067320
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of Lyn function in mast cell activation by SH3 domain binding peptides.
Stauffer TP; Martenson CH; Rider JE; Kay BK; Meyer T
Biochemistry; 1997 Aug; 36(31):9388-94. PubMed ID: 9235982
[TBL] [Abstract][Full Text] [Related]
35. Directed discovery of bivalent peptide ligands to an SH3 domain.
Ferguson MR; Fan X; Mukherjee M; Luo J; Khan R; Ferreon JC; Hilser VJ; Shope RE; Fox RO
Protein Sci; 2004 Mar; 13(3):626-32. PubMed ID: 14978303
[TBL] [Abstract][Full Text] [Related]
36. Crystal structure of the SH3 domain of human Lyn non-receptor tyrosine kinase.
Berndt S; Gurevich VV; Iverson TM
PLoS One; 2019; 14(4):e0215140. PubMed ID: 30969999
[TBL] [Abstract][Full Text] [Related]
37. Src family kinases: regulation of their activities, levels and identification of new pathways.
Ingley E
Biochim Biophys Acta; 2008 Jan; 1784(1):56-65. PubMed ID: 17905674
[TBL] [Abstract][Full Text] [Related]
38. Identification of a Src kinase SH3 binding site in the C-terminal domain of the human ErbB2 receptor tyrosine kinase.
Bornet O; Nouailler M; Feracci M; Sebban-Kreuzer C; Byrne D; Halimi H; Morelli X; Badache A; Guerlesquin F
FEBS Lett; 2014 Jun; 588(12):2031-6. PubMed ID: 24815698
[TBL] [Abstract][Full Text] [Related]
39. Large-Scale Screening of Preferred Interactions of Human Src Homology-3 (SH3) Domains Using Native Target Proteins as Affinity Ligands.
Kazlauskas A; Schmotz C; Kesti T; Hepojoki J; Kleino I; Kaneko T; Li SS; Saksela K
Mol Cell Proteomics; 2016 Oct; 15(10):3270-3281. PubMed ID: 27440912
[TBL] [Abstract][Full Text] [Related]
40. Identification of Hydrophobic Interfaces in Protein-Ligand Complexes by Selective Saturation Transfer NMR Spectroscopy.
Ferrage F; Dutta K; Cowburn D
Molecules; 2015 Dec; 20(12):21992-9. PubMed ID: 26690112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
